Published in Drug Week, February 14th, 2003
The subcontract provides ID Biomedical with approximately $6 million to clone, express, and produce under current Good Manufacturing Practices a subunit recombinant plague vaccine antigen. The parties expect the majority of the project to be concluded this calendar year.
The plague, also known as "the Black Death," is caused by Yersinia pestis bacteria. In past centuries, there have been over 150 recorded epidemics and pandemics of the plague, including a pandemic that killed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.